Quarterly report pursuant to Section 13 or 15(d)

Debt - Narrative (Details)

v3.22.2.2
Debt - Narrative (Details) - USD ($)
shares in Millions
3 Months Ended 9 Months Ended
Apr. 21, 2022
Apr. 14, 2020
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Debt Instrument [Line Items]                
Convertible notes, at fair value     $ 0     $ 0   $ 24,705,000
Accrued interest     0     0   232,222
Change in fair value and loss on exchange of convertible notes           (1,769,857) $ 27,600,000  
Convertible notes                
Debt Instrument [Line Items]                
Convertible notes, at fair value     $ 0     $ 0   24,700,000
Senior Secured Convertible Notes Due 2024 | Convertible notes                
Debt Instrument [Line Items]                
Interest rate     4.00%     4.00%    
Face amount     $ 0     $ 0   $ 27,500,000
Conversion of convertible note, amount $ 27,500,000              
Shares issued upon conversion (in shares) 7.8              
Long-term debt, gross $ 29,400,000              
Redemption price, percentage 107.00%              
Accrued interest $ 300,000              
Change in fair value and loss on exchange of convertible notes       $ (1,800,000)        
Adjustment to the fair value       400,000        
Interest expense     $ 0   $ 2,000,000 $ 332,707 5,977,777  
Senior Secured Convertible Notes Due 2024 | Convertible notes | Reclassification out of Accumulated Other Comprehensive Income                
Debt Instrument [Line Items]                
Interest expense       $ 1,400,000        
Paycheck Protection Program Term Note                
Debt Instrument [Line Items]                
CARES Act, proceeds from loans payable   $ 1,400,000         $ 1,400,000  
CARES Act, interest rate   1.00%